logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Synthetic Biologics, Inc.


USPTO Granted Patents = 37



Trademarks = 1

Forward Citations = 90

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Michael Kaleko (22 out of 59 patents)

silverMedal Sheila Connelly (19 out of 31 patents)

bronzeMedal Pertti Koski (8 out of 11 patents)

4.  Ulla Airaksinen (8 out of 12 patents)

5.  Katja Valimaki (8 out of 9 patents)

6.  Andrew Bristol (4 out of 8 patents)

7.  Vincent Wacher (4 out of 7 patents)

8.  Ellen Wagner (3 out of 5 patents)

9.  Annalee Nguyen (3 out of 8 patents)

10.  Eduardo Padlan (3 out of 3 patents)

11.  Jennifer A Maynard (3 out of 8 patents)

12.  Mark Pimentel (2 out of 57 patents)

13.  Vince Wacher (2 out of 6 patents)

14.  Christian Furlan Freguia (2 out of 6 patents)

15.  Joseph Sliman (2 out of 3 patents)


37 patents:

1. 11542510 - -based production of beta-lactamase (2023-01-03),
2. 11517614 - Microbiome protection from oral antibiotics (2022-12-06),
3. 11338020 - Alkaline phosphatase agents for treatment of neurodevelopmental disorders (2022-05-24),
4. 11253577 - Safe and effective beta-lactamase dosing for microbiome protection (2022-02-22),
5. 11034966 - -based production of beta-lactamase (2021-06-15),
6. 10987410 - Alkaline phosphatase formulations (2021-04-27),
7. 10828260 - Beta-lactamase formulations and uses thereof (2020-11-10),
8. 10792346 - Method and compositions for inhibiting or preventing adverse effects of oral antibiotics (2020-10-06),
9. 10767171 - Beta-lactamases with improved properties for therapy (2020-09-08),
10. 10736871 - Anti-methanogenic lovastatin analogs or derivatives and uses thereof (2020-08-11),
11. 10709773 - Safe and effective beta-lactamase dosing for microbiome protection (2020-07-14),
12. 10584326 - Beta-lactamases with improved properties for therapy (2020-03-10),
13. 10548955 - Carbapenemases for use with antibiotics for the protection of the intestinal microbiome (2020-02-04),
14. 10526400 - Humanized pertussis antibodies and used thereof (2020-01-07),
15. 10336995 - Beta-lactamases with improved properties for therapy (2019-07-02),
Synthetic Biologics, Inc. is a clinical-stage biotechnology company focused on developing therapeutics to protect the microbiome. The company's pipeline includes novel microbiome-focused drug candidates designed to prevent or treat serious diseases, including a phase 2 candidate for the prevention of C. difficile infection. Synthetic Biologics aims to leverage the potential of the microbiome to improve human health and provide breakthrough treatments for various conditions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

37 Patents

#15 in Rockville, MD

#102 in Maryland

#8,939 in US

#17,698 in the World

...
Rockville, MD, United States of America

Synthetic Biologics, Inc.

Forward Citations = 90

35 inventors:

goldMedal Michael Kaleko (22 out of 59 patents)

silverMedal Sheila Connelly (19 out of 31 patents)

bronzeMedal Pertti Koski (8 out of 11 patents)

4.  Ulla Airaksinen (8 out of 12 patents)

5.  Katja Valimaki (8 out of 9 patents)

Please report any incorrect information to support@idiyas.com
Loading…